Drooid Logo
Back to story perspectives

Full Breakdown

FDA Allows Zyn Nicotine Pouches to Claim Lower Risk Than Cigarettes

8/9/2026, 12:25:23 AM

Core Decision and Advertising Scope

The agency clarified that the permission does not constitute FDA approval of the products as a smoking-cessation aid.

Health Risks Highlighted by Experts

Nicotine remains an addictive stimulant that activates central- nervous and cardiovascular systems. Researchers note that the evidence linking nicotine pouches to oral cancer is still insufficient, but the products can cause mouth inflammation and tissue damage. Studies of similar smokeless tobacco suggest plausible cardiovascular effects, though the direct evidence base is thin. The Centers for Disease Control and Prevention warns that nicotine can impair brain regions responsible for attention, learning, mood, and impulse control, especially in developing adolescents.

Youth Uptake and Market Dynamics

The 2025 National Youth Tobacco Survey reported that 1.7 % of middle- and high-school students used nicotine pouches, with ?90 % choosing flavored varieties—a modest rise from 1.1 % in 2022. Flavors such as cinnamon, citrus, coffee, menthol, and peppermint are promoted on social media and in convenience stores, increasing appeal among young people who have never smoked cigarettes.

Official Statements & Responses

Public-health officials emphasize that nicotine pouches are not a proven cessation method and that FDA approval would require drug-regulation standards and clinical trials. The CDC reiterates that nicotine exposure during adolescence can harm brain development. Experts anticipate that Zyn will not pursue formal FDA cessation approval, leaving the products regulated only as tobacco-derived items.

Verbatim Quotes

  • “Yes, it is safer than smoking cigarettes, but if you do not smoke cigarettes and are not using it as a cessation tool, it is best to not use these products,” — Aaron Hunt, Utah State University Health and Wellness extension specialist
  • “Oral and cardiovascular effects are biologically plausible, but the direct evidence base is thin to date,” — Aaron Hunt, Utah State University Health and Wellness extension specialist
  • “Smokers might compare it to cigarettes, but young people who don't smoke might also interpret this to mean the products are safe,” — Dr. Pamela Ling, director, UCSF Center for Tobacco Control Research and Education
  • “Kids who were never smoking cigarettes in the first place are a growing share of pouch users,” — Aaron Hunt, Utah State University Health and Wellness extension specialist
  • “From a harm reduction standpoint, that's promising,” — Johannes Thrul, Johns Hopkins University substance-use disorder researcher
  • “To be effective, it's very important to use nicotine replacement with counseling to support plans to quit,” — Dr. Pamela Ling, director, UCSF Center for Tobacco Control Research and Education